Evidence map›Paper›PMID 20622153›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Phosphorylation stabilizes Nanog by promoting its interaction with Pin1.

Matteo Moretto-Zita, Hua Jin, Zhouxin Shen, Tongbiao Zhao, Steven P Briggs, Yang Xu

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02616484 (Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency), which is not on this map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02616484 phase3active not recruitingnot on this mapstarted 2020, after this paper: background citation

Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:

TypeinterventionalSponsorSaol Therapeutics IncRan2020 to 2025Enrolled34ConditionsPyruvate Dehydrogenase Complex DeficiencyArmsDichloroacetate (DCA), Placebo, Genotype
3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pin1 promotes human CaCell communication and signaling : CCS · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Post-translational Modifications of the Peptidyl-Prolyl Isomerase Pin1.Frontiers in cell and developmental biology · 2020
    Review
  19. Review
  20. Pinning Down the Transcription: A Role for Peptidyl-ProlylFrontiers in cell and developmental biology · 2020
    Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Matteo Moretto-ZitaSection of Molecular Biology and Cell and Developmental Biology, Division of Biological Sciences, University of California, La Jolla, CA 92093-0322, USA.
Hua Jin
Zhouxin Shen
Tongbiao Zhao
Steven P Briggs
Yang Xu
Institute of Macromolecular Chemistry · UAUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Embryonic stem cells (ESCs) can undergo unlimited self-renewal and retain the pluripotency to differentiate into all cell types in the body, thus holding great promise as a renewable source of cells for human therapy. The mechanisms that maintain self-renewal of ESCs remain unclear. Here we show that Nanog, a transcription factor crucial for the self-renewal of ESCs, is phosphorylated at multiple Ser/Thr-Pro motifs. This phosphorylation promotes the interaction between Nanog and the prolyl isomerase Pin1, leading to Nanog stabilization by suppressing its ubiquitination. Inhibition of Pin1 activity or disruption of Pin1-Nanog interaction in ESCs suppresses their capability to self-renew and to form teratomas in immunodeficient mice. Therefore, in addition to the stringent transcriptional regulation of Nanog, the expression level of Nanog is also modulated by posttranslational mechanisms.

Indexed as

Amino Acid MotifsAmino Acid SequenceAnimalsBinding SitesBlotting, WesternCell LineCells, CulturedEmbryonic Stem CellsEnzyme InhibitorsHomeodomain ProteinsHumansMiceMice, SCIDMolecular Sequence DataMutationNanog Homeobox Proteindiethyl-1,3,6,8-tetrahydro-1,3,6,8-tetraoxobenzo(lmn)(3,8)phenanthroline-2,7-diacetateEnzyme InhibitorsHomeodomain ProteinsNanog Homeobox ProteinNANOG protein, humanNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePhenanthrolinesPIN1 protein, humanPin1 protein, mouse

Identifiers

PMID20622153
PMCPMC2922169
OpenAlexW2046740266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.